{
  "summary": "The document is a Rights Agreement dated November 17, 2025, between Oramed Pharmaceuticals Inc. and Continental Stock Transfer & Trust Company, outlining the terms for issuing common share purchase rights to shareholders. The agreement details the conditions under which these rights can be exercised, adjusted, or redeemed, and defines key terms such as \"Acquiring Person\" and \"Beneficial Owner.\" It also specifies the roles and responsibilities of the Rights Agent and the procedures for handling the rights certificates.",
  "cot_examples": [
    {
      "messages": [
        {
          "role": "user",
          "content": [
            {
              "text": "Does the private placement exemption under Regulation D require SEC registration for accredited investors?"
            }
          ]
        },
        {
          "role": "assistant",
          "content": [
            {
              "text": "{\"Query analysis\": {\"Type\": \"regulatory_compliance_analysis\", \"Information needed\": \"Regulation D requirements and registration exemptions\", \"Tools\": [{\"Tool\": \"statute_retrieval\", \"Parameters\": {\"regulation\": \"Regulation D Rule 506\"}, \"Reasoning\": \"First retrieve exact text of Rule 506 to understand accredited investor exemptions\"}, {\"Tool\": \"compliance_checker\", \"Parameters\": {\"query\": \"Registration requirement verification\", \"edgar_check\": \"\", \"regulation\": \"Regulation D Rule 506\", \"case_interpretation_check\": \"\"}, \"Reasoning\": \"Validate whether SEC registration is needed using retrieved regulatory text\"}]}}"
            }
          ]
        }
      ]
    },
    {
      "messages": [
        {
          "role": "user",
          "content": [
            {
              "text": "Verify if 'SEC v. Ralston' properly applied Section 5 registration requirements to international token sales"
            }
          ]
        },
        {
          "role": "assistant",
          "content": [
            {
              "text": "{\"Query analysis\": {\"Type\": \"judicial_compliance_assessment\", \"Information needed\": \"Case application of Section 5 to cross-border transactions\", \"Tools\": [{\"Tool\": \"case_law_search\", \"Parameters\": {\"query\": \"SEC v. Ralston international application of Section 5\"}, \"Reasoning\": \"Need judicial reasoning from the case about international scope\"}, {\"Tool\": \"compliance_checker\", \"Parameters\": {\"query\": \"Token sale registration compliance\", \"edgar_check\": \"\", \"regulation\": \"Section 5\", \"case_interpretation_check\": \"Ralston precedent\"}, \"Reasoning\": \"Validate if case correctly applied registration rules to token sales\"}]}}"
            }
          ]
        }
      ]
    },
    {
      "messages": [
        {
          "role": "user",
          "content": [
            {
              "text": "Check if XYZ Corp's 144A offering circular complies with Rule 144A(d)(4) information requirements"
            }
          ]
        },
        {
          "role": "assistant",
          "content": [
            {
              "text": "{\"Query analysis\": {\"Type\": \"compliance_validation\", \"Information needed\": \"Specific disclosure obligations\", \"Tools\": [{\"Tool\": \"compliance_checker\", \"Parameters\": {\"query\": \"Rule 144A disclosure compliance\", \"edgar_check\": \"XYZ Corp offering circular language\", \"regulation\": \"Rule 144A(d)(4)\", \"case_interpretation_check\": \"\"}, \"Reasoning\": \"Direct validation against explicit regulatory disclosure requirements without needing case law\"}]}}"
            }
          ]
        }
      ]
    }
  ],
  "conversations": []
}